Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupFRA:3NX +1.75%81 5-Year Yield-on-Cost % is 2.02 as of Aug. 10, 2026, which is 23% above its 10-year median of 1.64. GuruFocus rates FRA:3NX with a GF Score™ of 81/100 and a GF Value™ of €0.32. The stock has 8 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Jinxin Fertility Group ranks worse than 62.91% on this metric.
Jinxin Fertility Group's yield on cost for the quarter that ended in Dec. 2025 was 2.02.
The historical rank and industry rank for Jinxin Fertility Group's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:3NX'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.32 Med: 1.64 Max: 2.52
Current: 2.02
During the past 10 years, Jinxin Fertility Group's highest Yield on Cost was 2.52. The lowest was 0.32. And the median was 1.64.
FRA:3NX's 5-Year Yield-on-Cost % is ranked worse than 62.91% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs FRA:3NX: 2.02
Jinxin Fertility Group (FRA:3NX) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Jinxin Fertility Group 5-Year Yield-on-Cost % Related Terms
FRA:3NX vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's 5-Year Yield-on-Cost % falls into.
Jinxin Fertility Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Jinxin Fertility Group (FRA:3NX) has a 5-Year Yield-on-Cost % of 2.02 as of Aug. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jinxin Fertility Group and its competitors. This is 23% above median its historical median of 1.64. Over the past decade, Jinxin Fertility Group's 5-Year Yield-on-Cost % has ranged from 0.32 to 2.52. According to the industry distribution chart, Jinxin Fertility Group ranks #173 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 62.9%.
Is Jinxin Fertility Group's 5-Year Yield-on-Cost % too high?
Jinxin Fertility Group's current 5-Year Yield-on-Cost % of 2.02 is 23% above median its 10-year median of 1.64. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 2.52. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Jinxin Fertility Group's value of 2.02 is 30.3% below this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #173 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Jinxin Fertility Group has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #173 out of 275 companies for 5-Year Yield-on-Cost %. This places Jinxin Fertility Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Jinxin Fertility Group's value of 2.02 is 30.3% below this benchmark. Historically, Jinxin Fertility Group's own 5-Year Yield-on-Cost % has ranged from 0.32 to 2.52 over the past decade. While the company's 10-year median is 1.64 vs. the industry median of 2.90, Jinxin Fertility Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current 5-Year Yield-on-Cost % of 2.02 is 30.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current 5-Year Yield-on-Cost % is 2.02, which is 23% above median its own 10-year median of 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (FRA:3NX) has a current 5-Year Yield-on-Cost % of 2.02. The stock's GF Value™ is €0.32, compared to a current price of €0.23 — trading 27.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.02, which is 23% above median its 10-year median of 1.64 and 30.3% below the Healthcare Providers & Services industry median of 2.90. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Jinxin Fertility Group (FRA:3NX), the current 5-Year Yield-on-Cost % is 2.02 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (FRA:3NX) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of €0.23 is trading 27.5% below its estimated GF Value™ of €0.32.
Key valuation signals for FRA:3NX:
5-Year Yield-on-Cost %: 2.02 (23% above median its 10-year median of 1.64)
GF Value™: €0.32 vs. price of €0.23 (27.5% below fair value)
Industry Position: 30.3% below the Healthcare Providers & Services median (#173 of 275)
No single metric tells the full story. See the FRA:3NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for FRA:3NX
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3NX has been successfully added to your 
